Jack Higgins is Chief Scientific Officer of Immunome Inc.. Currently has a direct ownership of 37,729 shares of IMNM, which is worth approximately $646,675. The most recent transaction as insider was on Dec 19, 2025, when has been sold 3,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.7K
7.37% 3M change
178.88% 12M change
Total Value Held $646,675

Jack Higgins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2025
SELL
Bona fide gift
-
3,000 Reduced 7.37%
37,729 Common Stock
Sep 10 2025
BUY
Exercise of conversion of derivative security
$29,700 $1.35 p/Share
22,000 Added 35.07%
40,729 Common Stock
Mar 27 2025
BUY
Exercise of conversion of derivative security
$7,020 $1.35 p/Share
5,200 Added 21.73%
18,729 Common Stock
Aug 19 2024
SELL
Bona fide gift
-
2,471 Reduced 15.44%
13,529 Common Stock
Aug 15 2024
SELL
Open market or private sale
$49,089 $13.93 p/Share
3,524 Reduced 18.05%
16,000 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
$26,357 $1.35 p/Share
19,524 Added 50.0%
19,524 Common Stock
JH

Jack Higgins

Chief Scientific Officer
Exton, PA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Track Activities on IMNM